13F Holdings
中文EN

LIVN LivaNova PLC

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1639691 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.7%
TTM net income YoY190.1%
TTM EPS YoY187.7%
Revenue 3-yr CAGR10.5%
Net income 3-yr CAGR308.9%

Margins

Gross margin67.8%
Operating margin10.7%
Net margin13.0%
FCF margin8.6%
EBITDA margin13.0%

Returns

ROE15.5%
ROA7.4%
ROIC (approx.)15.8%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets49.4%
Debt / equity0.22x
Current ratio1.46x
Interest coverage4.73x

Cash quality & payout

Operating cash flow / net income1.21x
Accruals ratio-1.6%
Payout ratio—
Capex / revenue7.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.39B$1.25B$1.15B$1.02B$1.04B
Cost of revenue$448.18M$399.95M$397.73M$314.58M$329.37M
Gross profit$939.87M$853.48M$755.82M$707.23M$705.99M
R&D expense$185.76M$182.51M$193.82M$155.81M$183.41M
SG&A expense$548.81M$508.88M$502.70M$469.24M$471.90M
Operating income$199.39M$129.05M-$68.50M-$76.75M-$784,000
Interest expense$49.29M$63.07M$58.85M$48.25M$50.15M
Pretax income-$220.78M$88.31M-$81.23M-$75.14M-$124.47M
Income tax$21.64M$25.06M-$98.88M$11.05M$11.20M
Net income-$242.47M$63.23M$17.55M-$86.25M-$135.82M
EBITDA$227.95M$154.16M-$43.76M-$54.38M$23.75M
EPS (basic)-4.451.170.33-1.61-2.68
EPS (diluted)-4.451.160.32-1.61-2.68
Weighted avg. shares (diluted)54.55M54.57M54.21M53.47M50.63M
Balance sheet
Cash & equivalents$635.55M$723.56M$266.50M$515.62M$207.99M
Receivables$215.99M$193.16M$215.07M$183.11M$185.35M
Inventory$164.70M$147.57M$147.89M$129.38M$105.84M
Current assets$1.10B$1.13B$988.16M$886.14M$679.18M
PP&E, net$242.60M$170.26M$154.18M$147.19M$150.07M
Goodwill$792.84M$750.01M$782.94M$768.79M$899.52M
Intangibles$229.96M$237.29M$261.18M$368.56M$399.68M
Total assets$2.61B$2.51B$2.43B$2.29B$2.20B
Current liabilities$808.07M$392.12M$334.98M$297.40M$696.97M
Short-term debt$31.47M$78.00M$18.11M$23.43M$229.67M
Long-term debt$345.19M$549.62M$568.54M$518.07M$9.85M
Total debt$376.66M$627.63M$586.65M$541.50M$239.52M
Total liabilities$1.41B$1.19B$1.15B$1.09B$906.31M
Shareholders' equity$1.20B$1.32B$1.28B$1.21B$1.29B
Net debt-$258.89M-$95.93M$320.15M$25.88M$31.53M
Shares outstanding54.65M54.35M53.92M53.56M53.26M
Cash flow statement
Operating cash flow$254.34M$183.04M$74.91M$69.92M$102.54M
Capital expenditure$81.05M$47.11M$34.98M$26.52M$25.48M
Free cash flow$173.29M$135.93M$39.93M$43.40M$77.07M
Investing cash flow-$72.91M-$48.16M-$40.33M-$38.41M$36.90M
Financing cash flow-$285.66M$18.55M$21.48M$280.13M-$181.48M
Depreciation & amortization$28.56M$25.10M$24.74M$22.37M$24.54M
Stock-based compensation$36.29M$33.93M$36.35M$44.81M$40.56M

Free plan shows the latest 5 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.